Base
Notice2024-220692024-09-26

Notice Pursuant to the National Cooperative Research and Production Act of 1993-The Customer Experience Hub

Justice Department, Antitrust Division

Document Excerpt

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Justice Antitrust Division Notice is hereby given that, on July 3, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (“the Act”), The Customer Experience Hub (“CX Hub”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Advanced Functional Fabrics of America, Inc., Cambridge, MA; Alacura Medical Transport Management, Inc., Dallas, TX; Amazon Web Services, Inc., Seattle, WA; AMPEL LLC dba AMPEL BioSolutions LLC, Charlottesville, VA; Aptima, Inc., Woburn, MA; Avsana Labs, Inc., Dallas, TX; Axiom Space, Inc., Houston, TX; Be Well Texas, San Antonio, TX; BetterAge, Sunnyside, NY; Bexar County Hospital District dba University Health System, San Antonio, TX; BioCytics, Inc., Huntersville, NC; Boyd Biomedical, Inc., Lee, MA; ( printed page 78903) Carolina BioOncology Institute PLLC, Huntersville, NC; Clinicals Global Pty Ltd., Fortitude Valley, AUSTRALIA; Cure Experience Service LLC, New York, NY; DesignPlex Biomedical LLC, Fort Worth, TX; Detroit Association of Black Organizations, Inc. (DABO), Detroit, MI; DiversiTrials, Florence, KY; Dynocardia, Inc., Cambridge, MA; Echo Investment Capital, Oklahoma

Read full document on FederalRegister.gov →

Full Document

Citation: 89 FR 78902